Related Experiment Videos
RaSH, a rapid subtraction hybridization approach for identifying and cloning differentially expressed genes
H Jiang1, D C Kang, D Alexandre
1Departments of Pathology, Urology, and Neurosurgery, Herbert Irving Comprehensive Cancer Center, Columbia University, College of Physicians and Surgeons, New York, NY 10032, USA.
Abstract:
Human melanoma cells growth-arrest irreversibly and terminally differentiate on treatment with a combination of fibroblast interferon and the protein kinase C activator mezerein. This experimental protocol also results in a loss of tumorigenic potential and profound changes in gene expression. Various cloning and cDNA microarray strategies are being used to determine the complete spectrum of gene expression changes underlying these alterations in human melanoma cells. An efficient approach, Rapid Subtraction Hybridization (RaSH), has been developed that is permitting the identification of genes of potential relevance to cancer growth control and terminal cell differentiation. RaSH cDNA libraries are prepared from double-stranded cDNAs that are enzymatically digested into small fragments, ligated to adapters, and PCR amplified followed by incubation of tester and driver PCR fragments. This subtraction hybridization scheme is technically simple and results in the identification of a high proportion of differentially expressed sequences, including known genes and those not described in current DNA databases. The RaSH approach represents an efficient methodology for identifying and cloning genes displaying differential expression that associate with and potentially regulate complex biological processes.
Insights
Fibroblast interferon and mezerein induce irreversible growth arrest and terminal differentiation in human melanoma cells. A novel Rapid Subtraction Hybridization (RaSH) method efficiently identifies genes involved in cancer growth control and cell differentiation.
Area of Science:
- Oncology
- Molecular Biology
- Gene Expression Analysis
Background:
- Human melanoma cells exhibit uncontrolled proliferation and tumorigenic potential.
- Terminal differentiation and growth arrest are key processes for cancer control.
- Understanding gene expression changes is crucial for developing targeted therapies.
Purpose of the Study:
- To identify genes regulating growth arrest and terminal differentiation in human melanoma.
- To develop an efficient method for detecting differentially expressed genes.
- To explore the molecular mechanisms underlying melanoma cell fate determination.
Main Methods:
- Treatment of human melanoma cells with fibroblast interferon and mezerein.
- Gene expression profiling using cDNA microarray and cloning strategies.
- Development and application of Rapid Subtraction Hybridization (RaSH) for gene identification.
Main Results:
- The combined treatment induced irreversible growth arrest and terminal differentiation.
- Significant changes in gene expression were observed in treated melanoma cells.
- RaSH successfully identified differentially expressed genes, including novel sequences.
Conclusions:
- The study presents an effective protocol for inducing melanoma cell differentiation and growth arrest.
- Rapid Subtraction Hybridization (RaSH) is an efficient tool for discovering genes related to cancer control.
- Identified genes may play critical roles in regulating melanoma cell fate and tumor suppression.